More recently, an observational study including SMARCA-UT patients and SMARCA4-deficient NSCLC reported three cases of patients with ALK mutation, including one EML4-ALK rearrangement [4]. This evidence concerns the gene SMARCA4 and non-small cell lung carcinoma.